Version 5.4
Bos taurus Protein: BT.21212
Summary
InnateDB Protein IDBP-694955.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.21212
Protein Name bile acyl-CoA synthetase
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000020170
InnateDB Gene IDBG-642489 (BT.21212)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0003824 catalytic activity
GO:0015245 fatty acid transporter activity
GO:0031957 very long-chain fatty acid-CoA ligase activity
Biological Process
GO:0000038 very long-chain fatty acid metabolic process
GO:0006642 triglyceride mobilization
GO:0006699 bile acid biosynthetic process
GO:0008152 metabolic process
GO:0008206 bile acid metabolic process
GO:0015908 fatty acid transport
GO:0015911 plasma membrane long-chain fatty acid transport
GO:0046951 ketone body biosynthetic process
Cellular Component
GO:0005783 endoplasmic reticulum
GO:0009925 basal plasma membrane
GO:0030176 integral component of endoplasmic reticulum membrane
Protein Structure and Domains
PDB ID
InterPro IPR000873 AMP-dependent synthetase/ligase
PFAM PF00501
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MX08
UniProt Splice Variant
Entrez Gene 533016
UniGene Bt.21212
RefSeq NP_001096743
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02047916 DAAA02047917
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca